BGM / BGM Group Ltd. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

BGM Group Ltd.

Mga Batayang Estadistika
CIK 1779578
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to BGM Group Ltd.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 14, 2025 EX-99.1

ACTING IN CONCERT AGREEMENT

Exhibit 99.1 ACTING IN CONCERT AGREEMENT This Acting in Concert Agreement (the "Agreement") is executed on July 5, 2025 by the following parties: a) Mr. Zhanchang Xin, a natural person of Chinese nationality with ID Card No.: [ ] ("Party A"); b) Party A's Holding Company: Ahanzhai Development Limited, a British Virgin Islands company ("Party A's Holding Company"); c) Ms. Furong Cao, a natural pers

August 14, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 BGM Group Ltd No. 152 Hongliang

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) I

July 24, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-39805

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-39805 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China Telephone: 86-028-64775180

July 24, 2025 EX-99.1

BGM GROUP LTD INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS

Table of Contents Exhibit 99.1 BGM GROUP LTD INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS CONTENTS PAGE(S) Unaudited Condensed Consolidated Balance Sheets as of March 31, 2025 and September 30, 2024 F-2 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Six Months Ended March 31, 2025, 2024 and 2023 F-3 Unaudited Co

July 24, 2025 EX-99.2

For the six months ended March 31, 2025

Exhibit 99.2 Financial Information Related to the VIE The following tables provide condensed consolidating schedules depicting the financial position, cash flows, and results of operations for the parent, subsidiaries, WFOE, the consolidated VIE, and any eliminating adjustments and consolidated totals as of March 31, 2025 and 2024 and for the six months ended March 31, 2025, 2024 and 2023. Selecte

June 26, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 BGM Group Ltd No. 152 Hongliang E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) Ind

June 3, 2025 EX-FILING FEES

Calculation of Filing Fee Tables (Form Type) BGM Group Ltd (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) BGM Group Ltd (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Fee Proposed Calculation Maximum Maximum Security or Carry Offering Aggregate Security Class Forward Amount Price Per Offering Amount of Type Title Rule Registered Unit Price Fee Rate Registration Fee Fees To Be Paid Equity Class A Ordinary Shares, par value $0.

June 3, 2025 EX-10.1

BGM Group Ltd 2025 EQUITY INCENTIVE PLAN ARTICLE 1

Exhibit 10.1 BGM Group Ltd 2025 EQUITY INCENTIVE PLAN ARTICLE 1 PURPOSE The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in ARTICLE 11. ARTICLE 2 ELIGIBILITY Service

June 3, 2025 S-8

As filed with the Securities and Exchange Commission on June 3, 2025

As filed with the Securities and Exchange Commission on June 3, 2025 Registration No.

May 28, 2025 EX-99.1

From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

Exhibit 99.1 From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts Chengdu, China, May 28, 2025 (PRNewswire) — BGM Group Ltd (the “Company” or BGM) (NASDAQ: BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., L

May 28, 2025 EX-99.2

TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, CANOE GROUP LTD, STARISLAND AI PTE. LTD, GREAT NAME GROUP LIMITED, XINGDAO AI ROBOT CO., LIMITED, YD NETWORK TECHNOLOGY COMPANY LIMITED XINGDAO COUNSULTANT MANAGEMENT (SHENZHEN) CO., LTD. XINGDAO INTE

Exhibit 99.2 TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, CANOE GROUP LTD, STARISLAND AI PTE. LTD, GREAT NAME GROUP LIMITED, XINGDAO AI ROBOT CO., LIMITED, YD NETWORK TECHNOLOGY COMPANY LIMITED XINGDAO COUNSULTANT MANAGEMENT (SHENZHEN) CO., LTD. XINGDAO INTELLEGENT CLOUD CHAIN (SHENZHEN) CO., LTD. AND THE OTHER PARTIES NAMED HEREIN DATED AS OF MAY 27, 2025 TABLE OF CONTENTS Page RECITALS 2 Ar

May 28, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 BGM Group Ltd No. 152 Hongliang Ea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) Indi

May 20, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 BGM Group Ltd No. 152 Hongliang Ea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) Indi

May 8, 2025 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yaxuan Zhai, certify that: 1. I have reviewed this annual report on Form 20-F, as amended by Amendment No. 3 thereto, of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untr

May 8, 2025 CORRESP

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China May 8, 2025 VIA EDGAR Ms. Lynn Dicker Ms. Tara Harkins Mr. Daniel Crawford Mr. Tim Buchmiller U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: BGM Group Ltd Form 20-F for F

May 8, 2025 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Chen Xin, certify that: 1. I have reviewed this annual report on Form 20-F, as amended by Amendment No. 3 thereto, of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untrue s

May 8, 2025 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Yaxuan Zhai, Chief Financial Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Repor

May 8, 2025 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Chen Xin, Chief Executive Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Report o

May 8, 2025 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 3) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 3) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECU

May 6, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 BGM Group Ltd No. 152 Hongliang Ea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) Indi

May 6, 2025 EX-99.1

BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

Exhibit 99.1 BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem Chengdu, China - May 2, 2025 (PRNewswire) - BGM Group Ltd. (Nasdaq: BGM) (the “Company” or “BGM”) , a leading AI technology company, today announced it has entered into a definitive agreement (the “Agreement”) to acquire HM Management Company Limited (“HM Management”), a prominent AI agent pr

May 6, 2025 EX-99.2

  TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, CATCH GROUP LTD. EXPANSION GROUP LTD HM MANAGEMENT COMPANY LIMITED HM CONSULTANT MANAGEMENT (SHENZHEN) CO., LIMITED BEIJING SHUDA TECHNOLOGY CO., LTD. NEW MEDIA STAR TECHNOLOGY (SHENZHEN) CO., LTD.

Exhibit 99.2    EXECUTION COPY       TRANSACTION AGREEMENT      BY AND AMONG   BGM GROUP LTD,   AND   CATCH GROUP LTD.   EXPANSION GROUP LTD   HM MANAGEMENT COMPANY LIMITED   HM CONSULTANT MANAGEMENT (SHENZHEN) CO., LIMITED   BEIJING SHUDA TECHNOLOGY CO., LTD.   NEW MEDIA STAR TECHNOLOGY (SHENZHEN) CO., LTD.   DATED AS OF MAY 2, 2025         TABLE OF CONTENTS            PAGE       RECITALS   1    

April 28, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 BGM Group Ltd No. 152 Hongliang

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) In

April 22, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 BGM Group Ltd No. 152 Hongliang

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) In

April 22, 2025 EX-99.1

BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

Exhibit 99.1 BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy CHENGDU, China, April 21, 2025 (PRNewswire) - BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited (“Wonder Dragon”), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordi

April 22, 2025 EX-99.2

TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, SUCCESS MYTH LIMITED WONDER DRAGON GLOBAL LIMITED YANG LOU DONG INTERNALTION LIMITED DATED AS OF APRIL 21, 2025 TABLE OF CONTENTS

Exhibit 99.2 EXECUTION COPY TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, AND SUCCESS MYTH LIMITED WONDER DRAGON GLOBAL LIMITED YANG LOU DONG INTERNALTION LIMITED DATED AS OF APRIL 21, 2025 TABLE OF CONTENTS Page RECITALS 1 Article 1 Definitions and Interpretation 1 Section 1.1. Definitions 1 Section 1.2. Interpretation 6 Article 2 Share Exchange 7 Section 2.1. Share Exchange 7 Section 2.2. Cl

April 3, 2025 CORRESP

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China April 3, 2025 VIA EDGAR Ms. Lynn Dicker Ms. Tara Harkins Mr. Daniel Crawford Mr. Tim Buchmiller U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: BGM Group Ltd Form 20-F for

April 3, 2025 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yaxuan Zhai, certify that: 1. I have reviewed this annual report on Form 20-F of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit

April 3, 2025 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Chen Xin, Chief Executive Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Report o

April 3, 2025 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 2) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 2) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR

April 3, 2025 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Yaxuan Zhai, Chief Financial Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Repor

April 3, 2025 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Chen Xin, certify that: 1. I have reviewed this annual report on Form 20-F of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to s

March 31, 2025 CORRESP

No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China

No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China March 31, 2025 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 U.S.A. Re: BGM Group Ltd Registration Statement on Form F-3, as amended (File No. 333-285635) Acceleration Request Ladies and Gentlemen: Pursuant to Rul

March 28, 2025 EX-99.1

RONS INTELLIGENT TECHNOLOGY (BEIJING) CO., LTD. AND SHENZHEN XINBAO INVESTMENT MANAGEMENT CO., LTD. INDEX TO COMBINED FINANCIAL STATEMENTS

Exhibit 99.1 RONS INTELLIGENT TECHNOLOGY (BEIJING) CO., LTD. AND SHENZHEN XINBAO INVESTMENT MANAGEMENT CO., LTD. INDEX TO COMBINED FINANCIAL STATEMENTS CONTENTS PAGE(S) REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID: 6907) F-2 COMBINED BALANCE SHEETS AS OF SEPTEMBER 30, 2023 AND 2024 F-3 COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEARS ENDED SEPTEMBER 30, 2

March 28, 2025 EX-99.2

Proforma BGM Group Ltd and Subsidiaries Consolidated Balance Sheets as of September 30,2024 (Expressed in U.S. Dollars, except for the number of shares)

Exhibit 99.2 Proforma BGM Group Ltd and Subsidiaries Consolidated Balance Sheets as of September 30,2024 (Expressed in U.S. Dollars, except for the number of shares) BGM Group Rons, Shenzhen Xinbao and its subsidiaries Adjustments Proforma As of September 30, 2024 $ $ $ $ ASSETS CURRENT ASSETS: Cash and cash equivalent 9,817,254 599,425 1,000,000 11,416,679 Restricted cash - 1,867,800 1,867,800 Ac

March 28, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 BGM Group Ltd No. 152 Hongliang

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) In

March 19, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 BGM Group Ltd No. 152 Hongliang

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office) In

March 19, 2025 EX-99.1

BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

Exhibit 99.1 BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform CHENGDU, China, March 19, 2025 (PRNewswire) - BGM Group Ltd. (the “Company” or BGM) (NASDAQ: BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd. (“YX”), a smart mobility technology company. Under the agreement, BGM will acquire 100% of the equi

March 19, 2025 EX-99.2

TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, MARTLINE LIMITED, CYMATRIX LIMITED, INNOVO LIMITED, TECHVOVO LIMITED, YX MANAGEMENT COMPANY LIMITED, THE OTHER PARTIES NAMED HEREIN DATED AS OF MARCH 18, 2025 TABLE OF CONTENTS

Exhibit 99.2 TRANSACTION AGREEMENT BY AND AMONG BGM GROUP LTD, MARTLINE LIMITED, CYMATRIX LIMITED, INNOVO LIMITED, TECHVOVO LIMITED, YX MANAGEMENT COMPANY LIMITED, AND THE OTHER PARTIES NAMED HEREIN DATED AS OF MARCH 18, 2025 TABLE OF CONTENTS Page RECITALS 1 Article 1 Definitions and Interpretation 2 Section 1.1. Definitions 2 Section 1.2. Interpretation 7 Article 2 Share Exchange 8 Section 2.1.

March 7, 2025 F-3

As filed with the Securities and Exchange Commission on March 7, 2025

As filed with the Securities and Exchange Commission on March 7, 2025 Registration No.

March 7, 2025 EX-FILING FEES

Calculation of Filing Fee Tables (Form Type) BGM GROUP LTD (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables F-3 (Form Type) BGM GROUP LTD (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to be paid Equity Class A Ordinary Shares, $0.

February 28, 2025 EX-99.1

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China

Exhibit 99.1 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China March 1, 2025 Dear Mr. Chen Xin, BGM Group Ltd, a Cayman Islands exempted company with limited liability (the “Company”), is pleased to offer you a position as the Chairman of the board of directors of the Company (the “Board”). We believe your background and expe

February 28, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 BGM Group Ltd No. 152 Honglia

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office)

February 28, 2025 EX-99.2

BGM GroupLtd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China

Exhibit 99.2 BGM GroupLtd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China March 1, 2025 Dear Mr. Lin Zhang, BGM Group Ltd, a Cayman Islands exempted company with limited liability (the “Company”), is pleased to offer you a position as an independent Director, Chairman of the Compensation Committee, members of the Audit Committee and Nomi

February 6, 2025 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Yaxuan Zhai, Chief Financial Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Repor

February 6, 2025 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No.1) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No.1) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECUR

February 6, 2025 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Chen Xin, Chief Executive Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Report o

February 6, 2025 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Chen Xin, certify that: 1. I have reviewed this annual report on Form 20-F, as amended by Amendment No. 1 thereto, of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untrue s

February 6, 2025 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yaxuan Zhai, certify that: 1. I have reviewed this annual report on Form 20-F, as amended by Amendment No. 1 thereto, of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untr

January 27, 2025 EX-15.1

January 27, 2025

Exhibit 15.1 January 27, 2025 To: BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings Item 3 Key Information—D. Risk Factors—Risks Related to Our Corporate Structure”, “Item 4 Information on the Company—B. Business Overview—Recent Regulato

January 27, 2025 EX-11.2

BGM GROUP LTD POLICY GOVERNING MATERIAL, NON-PUBLIC INFORMATION AND PREVENTION OF INSIDER TRADING

Exhibit 11.2 BGM GROUP LTD POLICY GOVERNING MATERIAL, NON-PUBLIC INFORMATION AND PREVENTION OF INSIDER TRADING I.OVERVIEW This Statement of Policy Governing Material, Non-Public Information and the Prevention of Insider Trading (this “Statement”) of the Company consists of three sections: Section I provides an overview; Section II sets forth the Company’s policies prohibiting insider trading; and

January 27, 2025 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Chen Xin, Chief Executive Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Report o

January 27, 2025 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Chen Xin, certify that: 1. I have reviewed this annual report on Form 20-F of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to s

January 27, 2025 EX-15.3

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (File No. 333-278591), Form F-3 (File No. 333-282998) and Form S-8 (File No. 333-278592) of BGM Group Ltd. (formerly known as Qilian International Holding Group Ltd.) and its affiliated entities (collectively, the “Company”) of our rep

January 27, 2025 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI

January 27, 2025 EX-97.1

BGM GROUP LTD POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

Exhibit 97.1 BGM GROUP LTD POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION A.OVERVIEW In accordance with the Listing Rule 5608(b) of Nasdaq Stock Market LLC (the “Nasdaq Rules”), Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 10D-1”), the Board of Directors (the “Board”) of BGM Group Ltd (the “Company”) has adopted this Policy

January 27, 2025 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yaxuan Zhai, certify that: 1. I have reviewed this annual report on Form 20-F of BGM Group Ltd; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit

January 27, 2025 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Yaxuan Zhai, Chief Financial Officer of BGM Group Ltd (the “Company”), hereby certify to my knowledge that: The Annual Repor

January 27, 2025 EX-15.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and Board of Directors of BGM Group Limited: We hereby consent to the incorporation by reference in the Registration Statement on Form F-3 (File No. 333-282998), Form F-3 (File No. 333-278591) and Form S-8 (File No. 333-278592), and consent to the inclusion in foregoing Form 20-F (File No. 001-38773) with SEC

January 7, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 BGM Group Ltd No. 152 Honglian

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office)

January 6, 2025 EX-2

BGM / BGM Group Ltd. / AIX Inc. - LIST OF DIRECTORS AND EXECUTIVE OFFICERS OF (I) AIX INC. AND (II) CISG HOLDINGS INC

Exhibit 2 DIRECTORS AND EXECUTIVE OFFICERS OF AIX INC. The business address of each of the following directors and executive officers is 60/F, Pearl River Tower, No. 15 West Zhujiang Road, Guangzhou, Guangdong 510623, People’s Republic of China. Name Citizenship Position Hang Suong Nguyen Vietnam Chairwoman of the Board Yinan Hu PRC Vice-Chairman of the Board and Chief Executive Officer Ning Li PR

January 6, 2025 EX-1

JOINT FILING AGREEMENT

Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, each of the undersigned parties hereby agrees to file jointly the statement on Schedule 13D (including any amendments thereto) with respect to the Class A Ordinary Share, par value $0.

December 3, 2024 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 tm2429887d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amend

December 3, 2024 SC 13D

BGM / BGM Group Ltd / LX Management Co Ltd - SC 13D Activist Investment

SC 13D 1 tm2429887d1sc13d.htm SC 13D United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 BGM Group Ltd (Name of Issuer) Class A Ordinary Shares, par value $0.00833335 per share (Title of Class of Securities) G7307E123** (CUSIP Number) Furong Cao Flat 1512, 15/F, Lucky Centre No.165-171 Wan Chai Road Wan Chai, 999077, Hong K

November 29, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 BGM Group Ltd No. 152 Honglia

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office)

November 29, 2024 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 tm2429587d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amend

November 29, 2024 SC 13D/A

BGM / BGM Group Ltd / Ahanzhai Development Ltd - SC 13D/A Activist Investment

SC 13D/A 1 tm2429587d1sc13da.htm SC 13D/A Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) BGM Group Ltd (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G7307E123** (CUSIP Number) Zhanchang Xin No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republ

November 29, 2024 EX-99.1

TRANSACTION AGREEMENT

  Exhibit 99.1   TRANSACTION AGREEMENT   BY AND AMONG   BGM GROUP LTD,   CISG HOLDING LTD,   PATRITION LIMITED,   GM MANAGEMENT COMPANY LIMITED,   DUXIAOBAO INTELLIGENT TECHNOLOGY (SHENZHEN) CO., LTD (度晓保智能科技(深圳)有限公司)   RONS INTELLIGENT TECHNOLOGY (BEIJING) CO., LTD. (榕数智能科技(北京)有限公司),   AND   THE OTHER PARTIES NAMED HEREIN   DATED AS OF NOVEMBER 27, 2024         TABLE OF CONTENTS           PAGE RE

November 27, 2024 EX-99.2

SHARE SUBSCRIPTION AGREEMENT

Exhibit 99.2 SHARE SUBSCRIPTION AGREEMENT THIS AGREEMENT is made on November 1, 2024., between the following parties: (1) LX Management Company Limited, a company duly incorporated and validly existing under the laws of Hong Kong, (the "Subscriber"); and (2) BGM Group Ltd, an exempt company with limited liability incorporated under the laws of Cayman Islands (Nasdaq: BGM) (the "Company"). The Subs

November 27, 2024 EX-99.1

SHARE SUBSCRIPTION AGREEMENT

Exhibit 99.1 SHARE SUBSCRIPTION AGREEMENT THIS AGREEMENT is made on November 1, 2024, between the following parties: (1) Ahanzhai Development Co., Ltd, a company duly incorporated and validly existing under the laws of the British Virgin Islands, (the "Subscriber"); and (2) BGM Group Ltd, an exempt company with limited liability incorporated under the laws of Cayman Islands (Nasdaq: BGM) (the "Com

November 27, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 BGM Group Ltd No. 152 Honglia

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of principal executive office)

November 22, 2024 CORRESP

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China

BGM Group Ltd No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C., 20549 November 22, 2024 Re: BGM Group Ltd Registration Statement on Form F-3 Filed November 5, 2024 File No. 333-282998 Ladies and Gentle

November 5, 2024 F-3

As filed with the Securities and Exchange Commission on November 5, 2024

As filed with the Securities and Exchange Commission on November 5, 2024 Registration No.

November 5, 2024 EX-FILING FEES

Calculation of Filing Fee Tables (Form Type) BGM GROUP LTD (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables F-3 (Form Type) BGM GROUP LTD (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to be paid Equity Class A Ordinary Shares, $0.

October 22, 2024 EX-1.1

The Companies Act (Revised) of the Cayman Islands Company Limited by Shares THIRD AMENDED AND RESTATED memorandum AND ARTICLES of association OF BGM Group Ltd (Adopted by special resolution passed on October 18, 2024 and made effective on October 18,

Exhibit 1.1 The Companies Act (Revised) of the Cayman Islands Company Limited by Shares THIRD AMENDED AND RESTATED memorandum AND ARTICLES of association OF BGM Group Ltd 博美集团有限公司 (Adopted by special resolution passed on October 18, 2024 and made effective on October 18, 2024) The Companies Act (Revised) of the Cayman Islands Company Limited by Shares THIRD AMENDED AND RESTATED Memorandum of Assoc

October 22, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Qilian International Holding G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Qilian International Holding Group Ltd. No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +86-028-64775180 (Address of pr

October 16, 2024 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 tm2425844d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amend

October 16, 2024 SC 13D

BGM / Qilian International Holding Group Limited / Ahanzhai Development Ltd - SC 13D Activist Investment

SC 13D 1 tm2425844d1sc13d.htm SC 13D Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 Qilian International Holding Group Limited (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G7307E123** (CUSIP Number) Zhanchang Xin No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Re

October 10, 2024 6-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Rep

September 9, 2024 EX-99.1

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 610200 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 18, 2024

Exhibit 99.1 Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 610200 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 18, 2024 TO THE SHAREHOLDERS OF QILIAN INTERNATIONAL HOLDING GROUP LIMITED: Notice is hereby given that Qilian International Holding Group Limited, a Cayman Islands company (the “C

September 9, 2024 EX-99.2

Please Vote, Sign, Date and Return Promptly in the Enclosed Envelope. 2024 Extraordinary General Meeting Proxy Card- Qilian International Holding Group Limited ▼ DETACH PROXY CARD HERE TO VOTE BY MAIL ▼ THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR”

Exhibit 99.2 VOTE ON INTERNET Go to http://www.vstocktransfer.com/proxy Click on Proxy Voter Login and log-on using the below control number. Voting will be open until 11:59 p.m. EDT on October 17, 2024. CONTROL # VOTE BY EMAIL Mark, sign and date your proxy card and return it to [email protected]. * SPECIMEN * No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 61

September 9, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Rep

August 14, 2024 EX-99.2

For the six months ended March 31, 2024

Exhibit 99.2 Financial Information Related to the VIE The following tables provide condensed consolidating schedules depicting the financial position, cash flows, and results of operations for the parent, subsidiaries, WFOE, the consolidated VIE, and any eliminating adjustments and consolidated totals as of March 31, 2024 and 2023 and for the six months ended March 31, 2024, 2023 and 2022. Selecte

August 14, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-398

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic o

August 14, 2024 EX-99.1

QILIAN INTERNATIONAL HOLDING GROUP LIMITED INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS

Table of Contents Exhibit 99.1 QILIAN INTERNATIONAL HOLDING GROUP LIMITED INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets as of March 31, 2024 and September 30, 2023 F-2 Condensed Consolidated Statements of Operations and Comprehensive Income for the six months ended March 31, 2024, 2023 and 20

June 6, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-39805

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-39805 Qilian International Holding Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +

June 6, 2024 EX-16.1

999 18th Street, Suite 3000, Denver, CO, 80202, USA. Phone: 1.303.386.7224 Fax: 1.303.386.7101 Email: [email protected]

Exhibit 16.1 June 6, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Dear Sir or Madam: We have been furnished with a copy of the Form 6-K for the event that occurred on June 6, 2024, to be filed by our former client, Qilian International Holding Group Limited. We agree with the statements concerning our firm contained in such Form 6-K. We have no position to agre

June 4, 2024 EX-10.1

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China

Exhibit 10.1 Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China May 31, 2024 Ms. Waihua Xu Room 207, No. 191, Yantian New Second Village, Xixiang Street, Baoan District, Shenzhen, China Re: Director Offer Letter Dear Ms. Waihua Xu, Qilian International Holding Group Limited, a Cayman Islands exempt

June 4, 2024 EX-10.4

EMPLOYMENT AGREEMENT

Exhibit 10.4 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of May 30, 2024 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Yaxuan Zhai, an individual (the “Chief Financial Officer (CFO)”). Except with respect to the direct employment of the CFO by the Com

June 4, 2024 EX-10.2

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China

Exhibit 10.2 Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China May 31, 2024 Ms. Furong Cao 14B West Tower Mixc Manor No. 37, Kefa Road, Yuehai Street, Nanshan District, Shenzhen, China Re: Director Offer Letter Dear Ms. Furong Cao, Qilian International Holding Group Limited, a Cayman Islands exemp

June 4, 2024 EX-10.3

EMPLOYMENT AGREEMENT

Exhibit 10.3 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of May 30, 2024 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Chen Xin, an individual (the “Chief Executive Officer (CEO)”). Except with respect to the direct employment of the CEO by the Compan

June 4, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-39805

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-39805 Qilian International Holding Group Ltd No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, 610200 People’s Republic of China +

May 15, 2024 CORRESP

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C., 20549 Attention: Lauren Hamill Alan Campbell May 15, 2024 Re: Qilian International Holding Group Limited Reg

May 8, 2024 CORRESP

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703 Tianfu New District, Chengdu, 610200 People’s Republic of China May 8, 2024 VIA EDGAR Ms. Lauren Hamill Mr. Alan Campbell U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group L

May 8, 2024 F-3/A

As filed with the Securities and Exchange Commission on May 8, 2024

As filed with the Securities and Exchange Commission on May 8, 2024 Registration No.

April 25, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-3980

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of

April 10, 2024 EX-FILING FEES

Calculation of Filing Fee Tables (Form Type) Qilian International Holding Group Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) Qilian International Holding Group Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Fee Proposed Calculation Maximum Maximum Security or Carry Offering Aggregate Security Class Forward Amount Price Per Offering Amount of Type Title Rule Registered(1) Unit Price Fee Rate Registration Fee Fees To Be Paid Equity Ordinary Shares, par value $0.

April 10, 2024 EX-4.5

QILIAN INTERNATIONAL HOLDING GROUP LIMITED (the “Issuer”) (the “Trustee”) Dated as of [●], 2024 Senior Debt Securities TABLE OF CONTENTS

Exhibit 4.5 QILIAN INTERNATIONAL HOLDING GROUP LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 2024 Senior Debt Securities TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of

April 10, 2024 EX-10.1

QILIAN INTERNATIONAL HOLDING GROUP LIMITED 2024 INCENTIVE AWARD PLAN ARTICLE 1

Exhibit 10.1 QILIAN INTERNATIONAL HOLDING GROUP LIMITED 2024 INCENTIVE AWARD PLAN ARTICLE 1 PURPOSE The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in ARTICLE 11. A

April 10, 2024 S-8

As filed with the Securities and Exchange Commission on April 9, 2024.

As filed with the Securities and Exchange Commission on April 9, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Qilian International Holding Group Limited (Exact Name of Registrant as Specified in Its Charter) Cayman Islands Not Applicable (State or Other Jurisdiction of (I.R.S. Em

April 10, 2024 EX-FILING FEES

Calculation of Filing Fee Tables (Form Type) QILIAN INTERNATIONAL HOLDING GROUP LIMITED (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

Exhibit 107 Calculation of Filing Fee Tables F-3 (Form Type) QILIAN INTERNATIONAL HOLDING GROUP LIMITED (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Fees to be paid Equity ordinary shares, $0.

April 10, 2024 F-3

As filed with the Securities and Exchange Commission on April 9, 2024

As filed with the Securities and Exchange Commission on April 9, 2024 Registration No.

April 10, 2024 EX-4.6

QILIAN INTERNATIONAL HOLDING GROUP LIMITED Dated as of [●], 2024 Subordinated Debt Securities TABLE OF CONTENTS

Exhibit 4.6 QILIAN INTERNATIONAL HOLDING GROUP LIMITED Issuer AND [TRUSTEE] Trustee INDENTURE Dated as of [●], 2024 Subordinated Debt Securities TABLE OF CONTENTS ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms. 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities. 4 Section 2.02 Form of Securities an

March 11, 2024 EX-99.2

Please Vote, Sign, Date and Return Promptly in the Enclosed Envelope. Extraordinary General Meeting Proxy Card- Qilian International Holding Group Limited. ▼ DETACH PROXY CARD HERE TO VOTE BY MAIL ▼ THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” FOR

Exhibit 99.2 VOTE ON INTERNET Go to http://www.vstocktransfer.com/proxy Click on Proxy Voter Login and log-on using the below control number. Voting will be open until 11:59 p.m. ET on April 18, 2024. CONTROL # VOTE BY EMAIL Mark, sign and date your proxy card and return it to [email protected]. * SPECIMEN * No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 61020

March 11, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-3980

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republi

March 11, 2024 EX-99.1

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District Chengdu, PRC 610200 People’s Republic of China Notice of Extraordinary General Meeting of Shareholders To Be Held on April 19, 2024, at 9 a.m.

Exhibit 99.1 Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District Chengdu, PRC 610200 People’s Republic of China Notice of Extraordinary General Meeting of Shareholders To Be Held on April 19, 2024, at 9 a.m. EST To the shareholders of Qilian International Holding Group Limited: NOTICE IS HEREBY GIVEN that Qilian International Holding Group Li

February 15, 2024 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue statemen

February 15, 2024 EX-15.1

February 15, 2024

Exhibit 15.1 February 15, 2024 To: Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings Item 3 Key Information—D. Risk Factors—Risks Related to Our Corporate Structure”, “Item 4 Information on the Company

February 15, 2024 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

February 15, 2024 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI

February 15, 2024 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue stateme

February 15, 2024 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

February 1, 2024 NT 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K x Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K x Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report

December 20, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic

December 7, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic

October 31, 2023 EX-99.1

Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 610200 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DCEMBER 5, 2023

Exhibit 99.1 Qilian International Holding Group Limited No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 610200 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DCEMBER 5, 2023 TO THE SHAREHOLDERS OF QILIAN INTERNATIONAL HOLDING GROUP LIMITED: Notice is hereby given that Qilian International Holding Group Limited, a Cayman Islands company (the “Co

October 31, 2023 EX-99.2

Please Vote, Sign, Date and Return Promptly in the Enclosed Envelope. 2023 Extraordinary General Meeting Proxy Card- Qilian International Holding Group Ltd. ▼ DETACH PROXY CARD HERE TO VOTE BY MAIL ▼ THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” FOR

Exhibit 99.2 VOTE ON INTERNET Go to http://www.vstocktransfer.com/proxy Click on Proxy Voter Login and log-on using the below control number. Voting will be open until 12 p.m. EDT on December 4, 2023. CONTROL # VOTE BY EMAIL Mark, sign and date your proxy card and return it to [email protected]. * SPECIMEN * No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, PRC 61020

October 31, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-39

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic

August 4, 2023 EX-99.1

Qilian International Holding Group Limited and Subsidiaries Condensed Consolidated Balance Sheets

Exhibit 99.1 Financial Highlights for the Six Months Ended March 31, 2023 For the Six Months Ended March 31, 2023 2022 % Change Revenue $ 29,163,616 $ 32,086,522 -9 % Gross profit $ 2,294,746 $ 3,502,491 -34 % Gross margin 7.9 % 10.9 % -3 % Income from operations $ 210,631 $ 1,227,245 -83 % Net income $ 439,380 $ 249,681 76 % Net Income attributable to Qilian International Holding Group Limited (“

August 4, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-398

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic o

July 25, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-39805

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-39805 Qilian International Holding Group Ltd Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of

June 14, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-39805

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic

April 26, 2023 EX-99.1

Qilian Received a Letter from Nasdaq Related to Regain Compliance

Exhibit 99.1 Qilian Received a Letter from Nasdaq Related to Regain Compliance JIUQUAN, China, April 26, 2023 /PRNewswire/ – Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, previously announced that on February 16, 2023, it received a written notice (the “Notice”) from the Listing Qualifications Depa

April 26, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 QILIAN INTERNATIONAL HOLDING GRO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 QILIAN INTERNATIONAL HOLDING GROUP LTD (Exact name of registrant as specified in its charter) Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000

April 19, 2023 EX-2.2

Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as Amended (the “Exchange Act”)

Exhibit 2.2 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as Amended (the “Exchange Act”) Ordinary shares, par value $0.00166667 per share (“Ordinary Shares”), of Qilian International Holding Group Limited (“we,” “our,” “our company,” or “us”) are registered under Section 12(b) of the Exchange Act and our Ordinary Shares are l

April 19, 2023 EX-15.1

April 14, 2023

EXHIBIT 15.1 April 14, 2023 To: Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings Item 3 Key Information—D. Risk Factors—Risks Related to Our Corporate Structure”, “Item 4 Information on the Company—B.

April 19, 2023 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

April 19, 2023 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue stateme

April 19, 2023 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

April 19, 2023 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue statemen

April 19, 2023 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI

February 23, 2023 EX-99.1

Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F

Exhibit 99.1 Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F JIUQUAN, China, February 23, 2023 /PRNewswire/ – Qilian International Holding Group Ltd (NASDAQ: QLI) (“Qilian” or the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced it has received a notice of non-compliance from Nasdaq Stock Mar

February 23, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 QILIAN INTERNATIONAL HOLDING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 QILIAN INTERNATIONAL HOLDING GROUP LTD (Exact name of registrant as specified in its charter) Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735

February 16, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 QILIAN INTERNATIONAL HOLDING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 QILIAN INTERNATIONAL HOLDING GROUP LTD (Exact name of registrant as specified in its charter) Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735

February 16, 2023 EX-99.1

Qilian International Holding Group Ltd Declares Special Cash Dividends to Shareholders

Exhibit 99.1 Qilian International Holding Group Ltd Declares Special Cash Dividends to Shareholders Jiuquan, China, February 16, 2023 /PRNewswire/ - Qilian International Holding Group Ltd (the "Company" or Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, announced today that the Company has declared a special one-time cash dividend of $0.05 per ordinary share, payable

January 31, 2023 NT 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 20-F 1 tm235028d1nt20f.htm NT 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 1

January 10, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the month of January 2023 Commission File Number: 001-39

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the month of January 2023 Commission File Number: 001-39805 Qilian International Holding Group Limited (Registrant’s name) Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 7

January 10, 2023 EX-16.1

Letter from Marcum Asia CPAs LLP dated January 10, 2023

Exhibit 16.1 January 10, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Qilian International Holding Group Limited under its Form 6-K dated January 10, 2023. We agree with the statements concerning our Firm in such Form 6-K; we are not in a position to agree or disagree with other statements of Qilian International

December 7, 2022 EX-10.2

Exclusive Service Agreement between Gansu Qilianshan Pharmaceutical Co.,Ltd. and Qilian Shan International Trade (Hainan) Co., Ltd dated December 1, 2022

Exhibit 10.2 THE EXCLUSIVE SERVICE AGREEMENT BETWEEN QILIAN SHAN INTERNATIONAL TRADE (HAINAN) CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. December 1, 2022 This EXCLUSIVE SERVICE AGREEMENT (this ?AGREEMENT?) is entered into as of December 1, 2022 (?SIGNING DATE?) in Jiuquan City, the People?s Republic of China (?CHINA? or ?PRC?) by and among the following Parties: (1) QILIAN SHAN INTERNA

December 7, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repu

December 7, 2022 EX-10.1

Exclusive Service Termination Agreement between Gansu Qilianshan Pharmaceutical Co.,Ltd. and Qilian International Trade (Chengdu) Co. Ltd dated December 1, 2022

Exhibit 10.1 AGREEMENT TO TERMINATE THE VIE SERVICE AGREEMENT This Termination Agreement is entered as of December 1, 2022 ("Effective Date") in Jiuquan City, the People?s Republic of China (?China? or ?PRC?) by and between the following Parties: (1) QILIAN INTERNATIONAL TRADE (CHENGDU) CO. LTD (?Chengdu Trade?), a limited liability company legally established under the laws of PRC, Registered Add

November 17, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repu

November 17, 2022 EX-16.1

Letter of Friedman LLP to the U.S. Securities and Exchange Commission dated November 17, 2022

Exhibit 16.1 November 17, 2022 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Dear Sir or Madam: We have read Form 6-K dated November 17, 2022 of Qilian International Holding Group Limited (?Registrant?) and are in agreement with the statements contained therein as it pertains to our firm; we are not in a position to agree or disagree with other statements of Registra

October 13, 2022 CORRESP

GANSU QUANYI LAW FIRM LEGAL OPINION Gansu Quanyi Law Firm Letter (2022) No. 004 PRC Legal Counsel of Gansu Qilianshan Pharmaceutical Co., Ltd Gansu Quanyi Law Firm Legal Opinion on Qilian International Holding Group Limited (the Company)’s 20-F Annua

LAWRENCE VENICK Partner 10100 Santa Monica Blvd. Suite 2200 Los Angeles, CA 90067 Direct Main Fax [email protected] 852.3923.1188 310.282.2000 310.282.2000 October 13, 2022 Mr. Michael Davis Divisions of Corporate Finance Office of Life Sciences U.S. Securities & Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Qilian International Holding Group Ltd. CIK 0001779578 Form 20-F/A2 for Fi

October 13, 2022 EX-15.1

Consent of Gansu Quanyi Law Firm

EXHIBIT 15.1 October 13, 2022 To: Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings Item 3 Key Information—D. Risk Factors—Risks Related to Our Corporate Structure”, “Item 4 Information on the Company—

October 13, 2022 EX-12.2

Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this Amendment No. 3 to annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain

October 13, 2022 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 3) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 3) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR

October 13, 2022 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

October 13, 2022 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

October 13, 2022 EX-12.1

Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this Amendment No. 3 to annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain

October 4, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number: 001-39

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repub

September 30, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Rep

September 30, 2022 EX-99.1

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022

Exhibit 99.1 Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022 Jiuquan, China, September 30, 2022 (GLOBE NEWSWIRE) - Qilian International Holding Group Limited (Nasdaq: QLI) (the ?Company?), a China-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fisc

August 29, 2022 EX-99.2

Please Vote, Sign, Date and Return Promptly in the Enclosed Envelope. 2022 Annual Meeting Proxy Card- Qilian International Holding Group Ltd. ▼ DETACH PROXY CARD HERE TO VOTE BY MAIL ▼ THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” ALL DIRECTOR NOMIN

EXHIBIT 99.2 VOTE ON INTERNET Go to http://www.vstocktransfer.com/proxy Click on Proxy Voter Login and log-on using the below control number. Voting will be open until 11:59 p.m. EDT on September 28, 2022. CONTROL # VOTE BY EMAIL Mark, sign and date your proxy card and return it to [email protected]. * SPECIMEN * 1 MAIN STREET ANYWHERE PA 99999-9999 VOTE BY MAIL Mark, sign and date your prox

August 29, 2022 EX-99.1

QILIAN INTERNATIONAL HOLDING GROUP LTD. Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China August 29, 2022

Exhibit 99.1 QILIAN INTERNATIONAL HOLDING GROUP LTD. Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Republic of China August 29, 2022 Dear Stockholder: You are cordially invited to attend the 2022 Annual General Meeting (the ?Meeting?) of Stockholders of Qilian International Holding Group Ltd. (the ?Company?) to be held at the corporate headquarte

August 29, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-398

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Republ

August 1, 2022 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

August 1, 2022 EX-12.1

Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this Amendment No. 2 to annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain

August 1, 2022 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 2) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 2) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR

August 1, 2022 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

August 1, 2022 EX-12.2

Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this Amendment No. 2 to annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain

July 29, 2022 CORRESP

LAWRENCE VENICK

LAWRENCE VENICK Partner 10100 Santa Monica Blvd. Suite 2200 Los Angeles, CA 90067 Direct 852.3923.1188 Main 310.282.2000 Fax 310.282.2000 [email protected] July 29, 2022 Mr. Michael Davis Divisions of Corporate Finance Office of Life Sciences U.S. Securities & Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Qilian International Holding Group Ltd. CIK 0001779578 Form 20-F/A1 for Fisca

June 30, 2022 EX-12.2

Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this Amendment No. 1 to annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain

June 30, 2022 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

June 30, 2022 EX-15.1

Consent of Gansu Quanyi Law Firm

EXHIBIT 15.1 June 16, 2022 To: Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings Item 3 Key Information—D. Risk Factors—Risks Related to Our Corporate Structure”, “Item 4 Information on the Company—B.

June 30, 2022 CORRESP

Via Edgar

Lawrence Venick Partner 10100 Santa Monica Boulevard Suite 2200 Los Angeles, CA 90067 Direct ????852.

June 30, 2022 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR

June 30, 2022 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

June 30, 2022 EX-12.1

Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this Amendment No. 1 to annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain

April 15, 2022 EX-10.2

Offer Letter to Qingling Zhang, dated April 15, 2022

Exhibit 10.2 Dear Mr. Qingling Zhang: We are very pleased that you have accepted to join our Board of Directors as an independent director, Chairperson of the Board?s nominating and corporate governance committee, and a member of the Board?s audit committee and the compensation committee as of April 15, 2022. We have been working hard to bring seasoned and experienced professionals to our Board of

April 15, 2022 EX-10.1

Offer Letter to Yixuan (Adam) Sun, dated April 15, 2022

Exhibit 10.1 Dear Mr. Yixuan (Adam) Sun: We are very pleased that you have accepted to join our Board of Directors as an independent director, Chairperson of the Board?s audit committee, and a member of the Board?s nominating and corporate governance committee and compensation committee as of April 15, 2022. We have been working hard to bring seasoned and experienced professionals to our Board of

April 15, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-3980

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Republi

February 11, 2022 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

February 11, 2022 EX-12.2

Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d- 14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue statemen

February 11, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repu

February 11, 2022 EX-4.11

English Translation of the Investment Agreement entered into by and between Chengdu QLS and Chongqing Jin Tong Industrial Construction Investment Co., Ltd., dated July 5, 2021

EX-4.11 4 tmb-20210930xex4d11.htm EX-4.11 Exhibit 4.11 Investment Agreement Party A: Chongqing Jintong Industrial Construction Investment Co., LTD Address: No. 123, Jintong Avenue, Zijia Street Office, Jannan District, Chongqing Legal representative: Xu Chuanxi Position: Chairman Party B: Chengdu Qilianshan Biotechnology Co., LTD Address: No. 8 yujian Road, Linqiong Industrial Park, Qiongwei City,

February 11, 2022 EX-4.10

English Translation of the Amendment to Amended Exclusive Service Agreement entered into by and between Qilian International Trade (Chengdu) Co., LTD, formerly known as Chengdu Qilian Trading co., Ltd., and Gansu Qilianshan Pharmaceutical Co., Ltd., dated February 25, 2021

Exhibit 4.10 ? EXCLUSIVE SERVICE SUPPLEMENTARY AGREEMENT AMENDMENT ? This EXCLUSIVE SERVICE SUPPLEMENTARY AGREEMENT AMENDMENT (this ? SUPPLEMENT AGREEMENT AMENDMENT?) is entered into as of February 25, 2021 (?SIGNING DATE?) in Jiuquan City, the People?s Republic of China (?CHINA? or ?PRC?) by and among the following Parties: ? (1)CHENGDU QILIAN TRADING Co., Ltd. (?CHENGDU QILIASN TRADING?), a limi

February 11, 2022 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

February 11, 2022 EX-2.2

Description of Securities

Exhibit 2.2 ? Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as Amended (the ?Exchange Act?) ? Ordinary shares, par value $0.00166667 per share (?Ordinary Shares?), of Qilian International Holding Group Limited (?we,? ?our,? ?our company,? or ?us?) are registered under Section 12(b) of the Exchange Act and our Ordinary Shares a

February 11, 2022 EX-12.1

Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue stateme

February 11, 2022 EX-99.1

Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results

Exhibit 99.1 Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results Jiuquan, China, Feburary 11, 2022 /PRNewswire/ - Qilian International Holding Group Limited (Nasdaq: QLI) (the ?Company?, ?Qilian International?, ?we?, ?our? or ?us?), a China-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the fiscal year

February 11, 2022 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

February 11, 2022 EX-15.1

Consent of Gansu Quanyi Law Firm

EX-15.1 10 tmb-20210930xex15d1.htm EX-15.1 EXHIBIT 15.1 February 11, 2022 To: Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings Item 3 Key Information—D. Risk Factors—Risks Related to Our Corporate Str

January 31, 2022 NT 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 20-F 1 tm224803d2nt20f.htm FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo

September 16, 2021 EX-99.1

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021

Exhibit 99.1 Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021 Jiuquan, China, September 16, 2021 (GLOBE NEWSWIRE) - Qilian International Holding Group Limited (Nasdaq: QLI) (the ?Company?), a China-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fisc

September 16, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Rep

March 9, 2021 20-F/A

- 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC

February 11, 2021 EX-13.2

Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Haiping Shi, Chief Financial Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my kno

February 11, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repu

February 11, 2021 20-F

- FORM 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

February 11, 2021 EX-12.2

Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Haiping Shi, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue statement

February 11, 2021 EX-12.1

Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zhanchang Xin, certify that: 1. I have reviewed this annual report on Form 20-F of Qilian International Holding Group Limited; 2. Based on my knowledge, this report does not contain any untrue stateme

February 11, 2021 EX-99.1

Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results

Exhibit 99.1 Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results Jiuquan, China, February 11, 2021 – Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced its financial results for the fiscal year ended September 30, 2020. Mr. Zhanchang Xin, Chairman and CEO of the

February 11, 2021 EX-13.1

Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Zhanchang Xin, Chief Executive Officer of Qilian International Holding Group Limited (the “Company”), hereby certify to my k

February 10, 2021 SC 13G

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXC

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Qilian International Holding Group Limited (Name of Issuer) Ordinary shares, $0.00166667 par value per share (Title of Class of Secu

February 10, 2021 EX-99.1

Joint Filing Agreement

Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s

February 10, 2021 EX-99.1

Joint Filing Agreement

Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s

February 10, 2021 SC 13G

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXC

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Qilian International Holding Group Limited (Name of Issuer) Ordinary shares, $0.00166667 par value per share (Title of Class of Secu

February 10, 2021 SC 13G

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXC

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Qilian International Holding Group Limited (Name of Issuer) Ordinary shares, $0.00166667 par value per share (Title of Class of Secu

February 10, 2021 EX-99.1

Joint Filing Agreement

Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s

January 20, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2021 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repub

January 20, 2021 EX-99.1

Qilian International Holding Group Limited Announces Full Exercise of Underwriters’ Over-Allotment Option

Exhibit 99.1 Qilian International Holding Group Limited Announces Full Exercise of Underwriters’ Over-Allotment Option Jiuquan, China, January 19, 2021 – Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the underwriters of its initial public offering ("Offering") have exercised in full their o

January 15, 2021 EX-99.2

Qilian International Holding Group Limited Announces Closing of Initial Public Offering

Exhibit 99.2 Qilian International Holding Group Limited Announces Closing of Initial Public Offering Jiuquan, China, January 14, 2021 – Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the closing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering pri

January 15, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2021 Commission File Number: 001-39805 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People?s Repub

January 15, 2021 EX-99.1

Qilian International Holding Group Limited Announces Pricing of Initial Public Offering

Exhibit 99.1 Qilian International Holding Group Limited Announces Pricing of Initial Public Offering Jiuquan, China, January 11, 2021 – Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00

January 12, 2021 424B4

5,000,000 Ordinary Shares Qilian International Holding Group Limited

Filed pursuant to Rule 424 (b)(4) Registration No. 333-234460 5,000,000 Ordinary Shares Qilian International Holding Group Limited We are offering 5,000,000 ordinary shares, par value $0.00166667 per share (“Ordinary Shares”). This is the initial public offering of our Ordinary Shares. The offering price of our Ordinary Shares in this offering is US $5.00 per Ordinary Share. Prior to this offering

December 28, 2020 CORRESP

Qilian International Holding Group Ltd.

Qilian International Holding Group Ltd. December 28, 2020 VIA EDGAR Ms. Sonia Bednarowski U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group Limited Registration Statement on Form F-1, as amended (File No. 333-234460) Request for Acceleration of Effect

December 28, 2020 CORRESP

December 28, 2020

December 28, 2020 VIA EDGAR Ms. Sonia Bednarowski U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Washington, DC 20549 Re: Qilian International Holding Group Limited Registration Statement on Form F-1, as amended (File No. 333-234460) Request for Acceleration of Effectiveness Dear Ms. Bednarowski: Pursuant to Rule 461 prom

December 23, 2020 EX-1.1

Form of Underwriting Agreement*

Exhibit 1.1 QILIAN INTERNATIONAL HOLDING GROUP LIMITED UNDERWRITING AGREEMENT [ ], 2020 Univest Securities, LLC 375 Park Avenue, 15th Floor New York, NY 10152 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, QILIAN INTERNATIONAL HOLDING GROUP LIMITED, a Cayman Islands exempted company (collectively with its subsidiaries and affiliates, includi

December 23, 2020 F-1/A

- F-1/A

As filed with the Securities and Exchange Commission on December 23, 2020 Registration No.

December 18, 2020 F-1/A

- F-1/A

As filed with the Securities and Exchange Commission on December 18, 2020 Registration No.

December 18, 2020 EX-1.1

Form of Underwriting Agreement*

Exhibit 1.1 QILIAN INTERNATIONAL HOLDING GROUP LIMITED UNDERWRITING AGREEMENT [ ], 2020 Univest Securities, LLC 375 Park Avenue, 15th Floor New York, NY 10152 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, QILIAN INTERNATIONAL HOLDING GROUP LIMITED, a Cayman Islands exempted company (collectively with its subsidiaries and affiliates, includi

December 14, 2020 8-A12B

- 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Qilian International Holding Group Limited (Exact name of registrant as specified in its charter) Cayman Islands Not applicable (State or other jurisdiction of incorporation or organization) (I.R

December 10, 2020 CORRESP

Qilian International Holding Group Ltd.

Qilian International Holding Group Ltd. December 10, 2020 VIA EDGAR Ms. Sonia Bednarowski U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group Ltd. Amendment No. 6 to Registration Statement on Form F-1 Filed November 23, 2020 File No. 333-234460 Dear Ms.

December 10, 2020 F-1/A

As filed with the Securities and Exchange Commission on December 10, 2020

As filed with the Securities and Exchange Commission on December 10, 2020 Registration No.

December 9, 2020 FWP

Qilian International Holding Group Limited 5,000,000 Ordinary Shares

Filed Pursuant to Rule 433 Registration Statement No. 333-234460 Issuer Free Writing Prospectus dated December 9, 2020 Relating to Preliminary Prospectus dated November 23, 2020 Qilian International Holding Group Limited 5,000,000 Ordinary Shares This free writing prospectus relates to the initial public offering of ordinary shares of Qilian International Holding Group Limited (the "Company") and

December 8, 2020 FWP

Qilian International Holding Group Limited 5,000,000 Ordinary Shares

Filed Pursuant to Rule 433 Registration Statement No. 333-234460 Issuer Free Writing Prospectus dated December 8, 2020 Relating to Preliminary Prospectus dated November 23, 2020 Qilian International Holding Group Limited 5,000,000 Ordinary Shares This free writing prospectus relates to the initial public offering of ordinary shares of Qilian International Holding Group Limited (the "Company") and

December 8, 2020 FWP

Qilian International Holding Group Limited 5,000,000 Ordinary Shares

Filed Pursuant to Rule 433 Registration Statement No. 333-234460 Issuer Free Writing Prospectus dated December 8, 2020 Relating to Preliminary Prospectus dated November 23, 2020 Qilian International Holding Group Limited 5,000,000 Ordinary Shares This free writing prospectus relates to the initial public offering of ordinary shares of Qilian International Holding Group Limited (the "Company") and

November 23, 2020 EX-99.4

Request for Waivers and Representation under Item 8.A.4 of Form 20-F**

Exhibit 99.4 QILIAN INTERNATIONAL HOLDING GROUP LIMITED Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province, 735000 People’s Republic of China +86-0937-2689523 November 23, 2020 Via Edgar Ms. Bonnie Baynes U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Q

November 23, 2020 F-1/A

- F-1/A

As filed with the Securities and Exchange Commission on November 23, 2020 Registration No.

August 21, 2020 EX-10.2

Employment Agreement by and between CFO Haiping Shi and the Company on June 15, 2020 (incorporated herein by reference to Exhibit 10.2 to our registration statement on Form F-1 (File No. 333-234460), as amended, initially filed with the SEC on November 4, 2019)

Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the ?Agreement?), is entered into as of June 15, 2020 (the ?Effective Date?), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the ?Company?), and Haiping Shi, an individual (the ?Chief Financial Officer (CFO)?). Except with respect to the direct employment of the CFO by the Co

August 21, 2020 EX-10.19

Form of Director Consent by David Moss**

Exhibit 10.19 CONSENT OF DAVID MOSS Qilian International Holding Group Limited (the ?Company?) intends to file a Registration Statement on Form F-1 (together with any amendments or supplements thereto, the ?Registration Statement?) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consent

August 21, 2020 EX-99.2

Frost & Sullivan Consent Letter**

Exhibit 99.2 1018, Tower B 500 Yunjin Road Shanghai, 200232, China Tel: 86 (21) 5407 5836 Fax: 86 (21) 3209 8500 www.frost.com August 19, 2020 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province People?s Republic of China Re: Consent of Frost & Sullivan (Beijing) Inc., Shanghai Branch Co. Ladies and Gentlemen, We understand th

August 21, 2020 EX-10.17

Unofficial English translation of Lease Agreement between Gansu Qilianshan Pharmaceutical Co. Ltd. and Ms. Jing Zhou, dated November 9, 2019**

Exhibit 10.17 All customers who collect any money from your employees are required to obtain a receipt voucher with our financial stamp. Customer Service Hotline :[ ] No: [ ] Housing rental contracts Lessor (hereinafter referred to as Party A): Zhou Jing ID: [ ] Address: [ ], Contact number: [ ] Lessee (hereinafter referred to as Party B): Xin Yuchang ID : [ ] Address: [ ] Contact number: [ ] Inte

August 21, 2020 EX-10.15

Unofficial English translation of Lease Agreement between Chengdu Qilianshan Biotechnology Co., Ltd. and Chengdu Dingsheng Jiaye Real Estate Brokerage Co., Ltd., dated October 19, 2019**

Exhibit 10.15 Lease contract [ ] Corresponding entrustment contract number: Party A (Lessor): Chengdu Dingsheng Jiaye Real Estate Brokerage Co., Ltd. Passport number: [ ] ID ¨ other Party B (Lessee): Party B (Agent): Lessee contact number: Signing Tips Emergency Contact: 1. Before signing the contract, Party A shall show Party B the house ownership certificate and other relevant certificates and s

August 21, 2020 F-1/A

- F-1/A

As filed with the Securities and Exchange Commission on August 21, 2020 Registration No.

August 21, 2020 EX-99.1

The PRC Pharmaceutical Industry Market Study by Frost & Sullivan dated August 2020**

Exhibit 99.1 The PRC Pharmaceutical Industry Market Study © 2019 Frost & Sullivan. All rights reserved. This document contains highly confidential information and is the sole property of Frost & Sullivan. No part of it may be circulated, quoted, copied or otherwise reproduced without the written approval of Frost & Sullivan. Highly Confidential February 2019 2 Agenda 2 Overview of the Macroeconomi

August 21, 2020 EX-10.18

Unofficial English translation of Lease Agreement between Chengdu Qilianshan Biotechnology Co., Ltd. and Sichuan Lianjia Real Estate Brokerage Co., Ltd., dated December 1, 2019**

Exhibit 10.18 1.1 Contract No .:100004730907 Housing rental contracts Sichuan Lianjia Real Estate Brokerage Co., Ltd. Signing Tips Client: 1. Each document included in this contract, you are required to sign in triplicate, please check the contents of the contract in triplicate (including manually completed parts) and ensure that the parties to the transaction and the broker each hold T points, pl

August 21, 2020 EX-10.16

Unofficial English translation of Lease Agreement between Gansu Qilianshan Pharmaceutical Co. Ltd. and Ms. Kunqiong Zeng, dated October 19, 2019**

Exhibit 10.16 Dear Customer, Any payment received from our employees shall be valid by issuing a receipt voucher with our financial seal. Customer Service Hotline: 4006 523 868 No:DTZL20190000722 Housing rental contracts Lessor (hereinafter referred to as Party A): Zeng Kunqiong ID :[ ] Address: [ ] Contact telephon:[ ] Lessee (hereinafter referred to as Party B): Xin Yuchang ID :[ ] Address: [ ]

June 12, 2020 CORRESP

Qilian International Holding Group Ltd.

Qilian International Holding Group Ltd. June 12, 2020 VIA EDGAR Ms. Bonnie Baynes U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group Ltd. Amendment No. 3 to Registration Statement on Form F-1 Filed April 8, 2020 File No. 377-02698 Dear Ms. Baynes: Qili

June 12, 2020 EX-99.2

Frost & Sullivan Consent Letter*

Exhibit 99.2 June 11, 2019 Qilian International Holding Group Limited Jiuquan Economic and Technological Development Zone Jiuquan City, Gansu Province People’s Republic of China Re: Consent of Frost & Sullivan (Beijing) Inc., Shanghai Branch Co. Ladies and Gentlemen, We understand that Qilian International Holding Group Limited (the “Company”) intends to file a draft registration statement (the “R

June 12, 2020 EX-99.1

The PRC Pharmaceutical Industry Market Study by Frost & Sullivan dated May 2020*

Exhibit 99.1 The PRC Pharmaceutical Industry Market Study © 2019 Frost & Sullivan. All rights reserved. This document contains highly confidential information and is the sole property of Frost & Sullivan. No part of it may be circulated, quoted, copied or otherwise reproduced without the written approval of Frost & Sullivan. Highly Confidential February 2019 2 Agenda 2 Overview of the Macroeconomi

June 12, 2020 F-1/A

- F-1/A

As filed with the Securities and Exchange Commission on June 12, 2020 Registration No.

June 12, 2020 EX-10.12

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Agricultural Development Bank of China, dated February 10, 2020**

Exhibit 10.12 No. : 62210201-2020 (suzhou) no. 0012 Working Capital Loan Contract AGRICULTURAL DEVELOPMENT BANK OF CHINA Borrower (full name): Gansu Qilianshan Pharmaceutical Co. Ltd. Business license no. : 91620900789633293L Legal representative/CEO: Zhanchang Xin Place of business (address): Jiuquan High-tech Industrial Park, Jiuquan City, Gansu Province, China Zip: 735000 Bank and account numbe

June 12, 2020 EX-10.13

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Bank of Lanzhou, dated April 2, 2020**

Exhibit 10.13 BANK OF LANZHOU Loan contract Lanyin loan No. 102192020000015 of 2020 Bank of Lanzhou Limited by Share Ltd Special note 1. This Contract is made by and between the Borrower and the Lender on the basis of equality and voluntariness, and all the terms hereof are the true expression of the intentions of both parties.In order to protect the legitimate rights and interests of the Borrower

April 8, 2020 EX-10.14

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Agricultural Bank of China, dated March 20, 2020*

Exhibit 10.14 ABC(2016)1003-1 Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.:62010120200000291 Dear customers: to protect your rights and interests, please carefully read any and all terms of this contract (especially those in block letter) prior to execution of this contract) and pay attention to your rights and obligations in the contract. If you have any doubts or questio

April 8, 2020 F-1/A

As filed with the Securities and Exchange Commission on April 8, 2020

As filed with the Securities and Exchange Commission on April 8, 2020 Registration No.

April 8, 2020 EX-10.13

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Agricultural Bank of China, dated February 26, 2020*

EX-10.13 2 tm2015170d1ex10-13.htm EXHIBIT 10.13 Exhibit 10.13 ABC(2016)1003-1 Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.:62010120200000188 Dear customers: to protect your rights and interests, please carefully read any and all terms of this contract (especially those in block letter) prior to execution of this contract) and pay attention to your rights and obligations in

January 21, 2020 FWP

Qilian International Holding Group Limited (NYSE Proposed Ticker: QLI) INVESTOR PRESENTATION January 2020 Forwarding - Looking Statements This presentation contains forward - looking statements that reflect our current expectations and views of futur

Filed Pursuant to Rule 433 Issuer Free Writing Prospectus Dated January 21, 2020 Registration Statement No.

January 2, 2020 EX-10.10

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Agricultural Bank of China, dated May 21, 2019**

Exhibit 10.10 ABC(2016)1003-1 Agricultural Bank of China Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.:62010120190000719 Dear customers: to protect your rights and interests, please carefully read any and all terms of this contract (especially those in block letter) prior to execution of this contract) and pay attention to your rights and obligations in the contract. If you

January 2, 2020 CORRESP

Qilian International Holding Group Ltd.

Qilian International Holding Group Ltd. January 2, 2020 VIA EDGAR Ms. Bonnie Baynes U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group Ltd. Amendment No. 2 to Registration Statement on Form F-1 Submitted November 27, 2019 File No. 377-02698 Dear Ms. Ba

January 2, 2020 EX-10.9

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Agricultural Bank of China, dated March 25, 2019**

Exhibit 10.9 ABC(2016)1003-1 Agricultural Bank of China Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.:62010120190000361 Dear customers: to protect your rights and interests, please carefully read any and all terms of this contract (especially those in block letter) prior to execution of this contract) and pay attention to your rights and obligations in the contract. If you

January 2, 2020 EX-10.11

Unofficial English translation of Working Capital Loan Contract between Gansu Qilianshan Pharmaceutical Co., Ltd. and Agricultural Bank of China, dated July 12, 2019**

Exhibit 10.11 ABC(2016)1003-1 Agricultural Bank of China Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.: 62010120190001052 Dear customers: to protect your rights and interests, please carefully read any and all terms of this contract (especially those in block letter) prior to execution of this contract) and pay attention to your rights and obligations in the contract. If yo

January 2, 2020 F-1/A

As filed with the Securities and Exchange Commission on January 2, 2020

As filed with the Securities and Exchange Commission on January 2, 2020 Registration No.

November 27, 2019 F-1/A

As filed with the Securities and Exchange Commission on November 27, 2019

As filed with the Securities and Exchange Commission on November 27, 2019 Registration No.

November 27, 2019 EX-1.1

Form of Underwriting Agreement**

QILIAN INTERNATIONAL HOLDING GROUP LIMITED UNDERWRITING AGREEMENT [ ], 2020 Univest Securities, LLC 375 Park Avenue, 15th Floor New York, NY 10152 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, QILIAN INTERNATIONAL HOLDING GROUP LIMITED, a Cayman Islands exempted company (collectively with its subsidiaries and affiliates, including, without

November 27, 2019 EX-99.4

Request for Waiver and Representation under Item 8.A.4 of Form 20-F*

Exhibit 99.4 November 27, 2019 VIA EDGAR Ms. Bonnie Baynes U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group Ltd. Amended Registration Statement on Form F-1 CIK No. 0001779578 Request for Waiver and Representation under Item 8.A.4 of Form 20-F Dear Ms

November 27, 2019 CORRESP

Qilian International Holding Group Ltd.

Qilian International Holding Group Ltd. November 27, 2019 VIA EDGAR Ms. Bonnie Baynes U.S. Securities and Exchange Commission Division of Corporation Finance Office of Healthcare & Insurance 100 F Street, N.E. Mail Stop 4631 Washington, DC 20549 Re: Qilian International Holding Group Ltd. Amendment No. 1 to Registration Statement on Form F-1 Submitted November 1, 2019 File No. 377-02698 Dear Ms. B

November 27, 2019 EX-3.1

Amended and Restated Memorandum and Articles of Association**

Exhibit 3.1 Companies Law (Revised) Company Limited by Shares AMENDED AND RESTATED memorandum of association OF QILIAN INTERNATIONAL HOLDING GROUP LIMITED ???????????? (Adopted by special resolution passed on 16 October 2019) Companies Law (Revised) Company Limited by Shares Memorandum of Association of QILIAN INTERNATIONAL HOLDING GROUP LIMITED ???????????? (Adopted by special resolution passed o

November 4, 2019 EX-10.6

Form of Power of Attorney (included in Exhibit 10.6)**

Exhibit 10.6 SHAREHOLDERS? VOTING RIGHTS PROXY AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder?s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date] SHAREHOLDERS? VOTING RIGHTS PROXY AGREEMENT This SHAREHOLDERS? VOTING RIGHTS PROXY AGREEMENT (this ?AGREEMENT?) is entered into as of [Date] (?SIGNING DATE?) in [City], the People?s Republic of China (?CHINA? or ?PRC?) by and a

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista